Fuji Pharma Revenue

Fuji Pharma had revenue of 13.00B JPY in the quarter ending December 31, 2024, with 20.98% growth. This brings the company's revenue in the last twelve months to 48.39B, up 16.22% year-over-year. In the fiscal year ending September 30, 2024, Fuji Pharma had annual revenue of 46.14B with 12.84% growth.

Revenue (ttm)

48.39B

Revenue Growth

+16.22%

P/S Ratio

0.69

Revenue / Employee

29.19M

Employees

1,658

Market Cap

33.25B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	46.14B	5.25B	12.84%
Sep 30, 2023	40.89B	5.46B	15.42%
Sep 30, 2022	35.43B	1.44B	4.22%
Sep 30, 2021	33.99B	197.00M	0.58%
Sep 30, 2020	33.79B	-2.49B	-6.85%
Sep 30, 2019	Pro	Pro	Pro
Sep 30, 2018	Pro	Pro	Pro
Sep 30, 2017	Pro	Pro	Pro
Sep 30, 2016	Pro	Pro	Pro
Sep 30, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Daiichi Sankyo Company	1,886.26B
Takeda Pharmaceutical Company	4,579.02B
HOYA Corporation	838.60B
Terumo	1,011.15B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Olympus	993.33B

Revenue Rankings

Fuji Pharma News

2 months ago - Olic anticipates buoyant demand for contraceptives - Bangkok Post

More News